mRNA-1010
Latest
Moderna enters clinical trials for its mRNA-based flu vaccine
Moderna has injected its mRNA-derived vaccine for the seasonal flu into a human volunteer for the first time as part of a Phase 1/2 clinical study, the company announced on Wednesday.
